Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile
Authors
Keywords
-
Journal
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-05-08
DOI
10.1111/bcpt.13035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2017) Borja Ibanez et al. EUROPEAN HEART JOURNAL
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- Genomics of Adverse Drug Reactions
- (2017) Ana Alfirevic et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Effect of genetic variations on ticagrelor plasma levels and clinical outcomes
- (2015) Christoph Varenhorst et al. EUROPEAN HEART JOURNAL
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Statin Lactonization by Uridine 5′-Diphospho-glucuronosyltransferases (UGTs)
- (2015) Tom J. J. Schirris et al. MOLECULAR PHARMACEUTICS
- Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2
- (2014) Marco Ferrari et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review
- (2014) William J. Canestaro et al. GENETICS IN MEDICINE
- Adenosine-Mediated Effects of Ticagrelor
- (2014) Marco Cattaneo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety
- (2014) Paul P. Dobesh et al. PHARMACOTHERAPY
- A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteers
- (2013) Renli Teng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Applications of CYP450 Testing in the Clinical Setting
- (2013) C. F. Samer et al. Molecular Diagnosis & Therapy
- ATP-dependent transport of statins by human and rat MRP2/Mrp2
- (2013) Lucy C.J. Ellis et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Angiotensin Receptor Blockers Worsen Renal Function and Dyspnea on Ticagrelor: A Potential Ticagrelor-Angiotensin Receptor Blocker Interaction?
- (2012) James J. DiNicolantonio et al. CLINICAL CARDIOLOGY
- Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers
- (2012) Renli Teng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Clinical Implications of Pharmacogenetic Variation on the Effects of Statins
- (2010) Simran D.S. Maggo et al. DRUG SAFETY
- Transporter Pharmacogenetics and Statin Toxicity
- (2009) M Niemi CLINICAL PHARMACOLOGY & THERAPEUTICS
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Proximal Tubular Epithelium Actively Secretes but Does Not Retain Rosuvastatin
- (2008) A. Verhulst et al. MOLECULAR PHARMACOLOGY
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search